Short answer: Revenue cycle due diligence tests whether a target’s reported revenue will actually turn into cash after the deal closes. Review the claims data, test a short list of KPIs, check coding and payer mix, and look at how the billing team and systems are set up. Weak billing is a valuation risk and a post-close opportunity.
Why revenue cycle belongs in diligence
A practice can show strong charges and still collect poorly. Slow billing, high denials, and write-offs that are not tracked can all make collections, and so EBITDA, look better on paper than they are in practice. Billing also tends to be run differently in each practice of a group, so a buyer needs to see how much of the revenue cycle is documented, measured, and repeatable.
What to request from the target
| Request | Why it matters |
|---|---|
| 12 to 24 months of A/R aging by payer | Shows how much sits in older buckets and which payers are slow |
| Denial reports by payer, code, and reason | Shows whether denials are a coding, front-end, or payer problem |
| Charges, payments and adjustments by month | Shows whether collections track charges, and how large write-offs are |
| Charge entry and claim submission timing | Shows lag between the visit and the bill |
| Payer mix and contract terms | Shows concentration risk and reimbursement exposure |
| Coding level distribution by provider | Surfaces outliers that can become audit exposure |
| Billing org chart, tenure and vendor contracts | Shows key-person risk and any lock-in |
| EHR and billing system list | Shows how hard the practice will be to integrate |
| Credentialing and enrollment status | Gaps here can block revenue from new providers |
The KPIs to test first
HFMA’s MAP Keys give standard equations, which keep comparisons fair across practices. Four of them are a good starting set (HFMA MAP Keys):
| KPI | HFMA definition | What a weak number can mean |
|---|---|---|
| Net days in A/R | Net A/R divided by average daily net patient service revenue | Slow follow-up or payer issues |
| Remittance denial rate | Total claims denied divided by total claims remitted | Front-end or coding problems |
| Clean claim rate | Claims that pass edits with no manual intervention divided by claims accepted for billing | Errors before submission |
| Cost to collect | Total revenue cycle cost divided by total patient service cash collected | Inefficient staffing or tools |
HFMA organizes its MAP Keys into 29 KPIs across five domains: patient access, pre-billing, claims, account resolution, and financial management (HFMA). Ask the target to calculate each KPI the same way across every practice, and recalculate them yourself from claim-level data.
Red flags that affect value
- A/R that is concentrated in older buckets, or in a few slow payers.
- Denial rates that nobody tracks by cause.
- A long gap between the visit and the claim.
- Write-offs and adjustments that are not explained.
- Coding levels that differ sharply between similar providers.
- Billing knowledge that sits with one or two people.
- Different billing systems and workflows in every location.
- Credentialing gaps for recently hired providers.
What to standardize first after closing
Start with what makes the numbers comparable: one set of KPI definitions, one weekly reporting pack, and one denial reason taxonomy. Then fix the biggest sources of leakage, usually front-end errors and slow A/R follow-up, before moving systems. Sequencing matters more than adding staff or tools.
Download the RCM Diligence Checklist
A four page checklist with eight diligence sections and a KPI reference table, built for PE deal teams and operating partners.
How 4D Global helps portfolio groups
4D Global provides billing, A/R follow-up, denial management, and coding support to physician practices and mid-sized medical groups, working inside the EHR and practice management system each location already uses. 4D Global is HIPAA-compliant, SOC 2 Type II, ISO 9001:2015 and ISO 27001:2022 certified, and an HBMA member, and it combines digital tools with expert offshore teams. Download the RCM Diligence Checklist, see our services, or contact 4D Global for an RCM review.
Frequently asked questions
What is revenue cycle due diligence? It is a review of how a target practice or group bills, collects, and reports revenue, so a buyer can judge how reliable the revenue is and where collections can improve.
Why does the revenue cycle affect EBITDA in a healthcare deal? Collections, denials, write-offs, and the cost of running billing all flow into earnings, so weak billing can overstate the quality of revenue and hide improvement opportunities.
Which RCM metrics should a buyer review? Start with net days in A/R, remittance denial rate, clean claim rate, and cost to collect, using the standard HFMA MAP Keys equations, and add A/R aging by payer and charge entry timing.
What are common red flags in a target’s billing operation? Older A/R concentrated in a few payers, untracked denials, long gaps between visit and claim, unexplained write-offs, inconsistent coding, and heavy dependence on one or two billers.
What should be fixed first after closing? Standardize KPI definitions and weekly reporting first, then address the biggest sources of leakage, usually front-end errors and slow A/R follow-up.

